By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050



Company News
Teva (TEVA) Announces FDA Approval Of Proair Respiclick (Albuterol Sulfate) Inhalation Powder For Pediatric Asthma Patients Ages 4 To 11 4/29/2016 11:00:50 AM
Teva (TEVA) Presents New Data For SD-809 In Huntington Disease At 68th American Academy of Neurology Annual Meeting In Vancouver, B.C. 4/18/2016 11:12:00 AM
Teva (TEVA) To Present Data Highlighting Company’s Pipeline In Neurological Disorders At 68th American Academy of Neurology Annual Meeting 4/12/2016 10:21:56 AM
Takeda (TKPYY) and Teva (TEVA) Establish New Biz Venture “Teva Takeda Yakuhin Ltd.” for Japanese Generics 4/1/2016 5:55:32 AM
Teva (TEVA) Announces FDA Approval Of CINQAIR (Reslizumab) Injection 3/23/2016 10:00:59 AM
Teva (TEVA) Announces Launch Of Generic Campral® In The United States 3/22/2016 10:36:05 AM
Teva (TEVA) To Present At The Barclays Global Healthcare Conference 3/11/2016 10:50:33 AM
Teva (TEVA) Initiates Voluntary Nationwide Recall Of One Lot Of Amikacin Sulfate Injection USP 1 Gram/4ml (250 Mg/Ml) Vials Due To Glass Particulate Matter 3/10/2016 11:03:16 AM
Teva (TEVA) Receives Allergan (AGN) Approval For The Allergan (AGN) Generics Acquisition 3/10/2016 10:42:26 AM
Teva (TEVA) Completes Generic Pulmicort Respules Portfolio With The Launch Of Third Strength In The United States 3/9/2016 10:29:00 AM